Brain Cancer Canada Invests $75,000 in Groundbreaking Phase 2 Clinical Trial at Sunnybrook Health Sciences Centre to Target Hard-to-Treat Glioblastoma in Older Patients

TORONTO, May 14, 2026 (GLOBE NEWSWIRE) — Brain Cancer Canada (BCC), Canada’s only 100% volunteer-driven charity dedicated exclusively to funding brain cancer research nationwide to award $75,000 to a Phase 2 clinical trial led by Dr. Jaime Godoy Santin and colleagues at Sunnybrook Health Sciences Centre in Toronto, Ontario. The study titled “TEMPO trial: Daily... The post Brain Cancer Canada Invests $75,000 in Groundbreaking Phase 2 Clinical Trial at Sunnybrook Health Sciences Centre to Target Hard-to-Treat Glioblastoma in Older Patients appeared first on Montreal Gazette .

Original source: Montreal Gazette